Synthesis and in vitro antimicrobial evaluation of novel fluoroquinolone derivatives

European Journal of Medicinal Chemistry

Volumn 45, Issue 12, 2010, Pages 6101-6105

  Srinivasan, Shanmugam ^a   Beema Shafreen, Raja Mohmed ^a   Nithyanand, Paramasivam ^a   Manisankar, Paramasivam ^a   Pandian, Shunmugiah Karutha ^a  

^a ALAGAPPA UNIVERSITY   (India)

Author keywords

Antibacterial; Antifungal; Fluoroquinolones; Structure activity relationship

Indexed keywords

1 ETHENYL 6,8 DIFLUORO 7 (2 CYANOLPHENYL 1 PIPERAZINYL) 4(1H) OXOQUINOLINE 3 CARBOXYLIC ACID; 1 ETHENYL 6,8 DIFLUORO 7 (2 FLUOROPHENYL 1 PIPERAZINYL) 4(1H) OXOQUINOLINE 3 CARBOXYLIC ACID; 1 ETHENYL 6,8 DIFLUORO 7 (2,3 DICHLORO PHENYL 1 PIPERAZINYL) 4(1H) OXOQUINOLINE 3 CARBOXYLIC ACID; 1 ETHENYL 6,8 DIFLUORO 7 (4 BROMO PIPERIDINYL) 4(1H) OXOQUINOLINE 3 CARBOXYLIC ACID; 1 ETHENYL 6,8 DIFLUORO 7 (4 FLUOROPHENYL 1 PIPERAZINYL) 4(1H) OXOQUINOLINE 3 CARBOXYLIC ACID; 1 ETHENYL 6,8 DIFLUORO 7 (4 HYDROXYMETHYL PIPERIDINYL) 4(1H) OXOQUINOLINE 3 CARBOXYLIC ACID; 1 ETHENYL 6,8 DIFLUORO 7 (4 METHYL AMINO PIPERIDINYL) 4(1H) OXOQUINOLINE 3 CARBOXYLIC ACID; 1 ETHENYL 6,8 DIFLUORO 7 (4 METHYL PIPERIDINYL) 4(1H) OXOQUINOLINE 3 CARBOXYLIC ACID; 1 ETHENYL 6,8 DIFLUORO 7 (4 PIPERIDINO PIPERIDINYL) 4(1H) OXOQUINOLINE 3 CARBOXYLIC ACID; 1 ETHENYL 6,8 DIFLUORO 7 (N BENZYL 1 PIPERAZINYL) 4(1H) OXOQUINOLINE 3 CARBOXYLIC ACID; 1 ETHENYL 6,8 DIFLUORO 7 (N PHENYL 1 PIPERAZINYL) 4(1H) OXOQUINOLINE 3 CARBOXYLIC ACID; CIPROFLOXACIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; DRUG SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78649325628     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2010.09.036     Document Type: Article

References (23)

1. P. Chaudhary, R. Kumar, A.K. Verma, D. Singh, V. Yadav, A.K. Chhillar, G.L. Sharma, and R. Chandra Synthesis and antimicrobial activity of N-alkyl and N-aryl piperazine derivatives Bioorg. Med. Chem. 14 2006 1819 1826
2. C.S. Cooper, P.L. Klock, D.T.W. Chu, D.J. Hardy, R.N. Swanson, and J.J. Plattner Preparation and in vitro and in vivo evaluation of quinolones with selective activity against Gram-positive organisms J. Med. Chem. 35 1992 1392 1398
3. K.F. Croom, and K.L. Goa Levofloxacin: a review of its use in the treatment of bacterial infections in the United States Drugs 63 2003 2769 2802
4. V. Fanos, and L. Cataldi Amphotericin B-induced nephrotoxicity: a review J. Chemother. 12 2000 463 470
5. H. Koga, A. Itoh, S. Murayama, S. Suzue, and T. Irikura Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids J. Med. Chem. 23 1980 1358 1363
6. Forroumadi, S. Emami, A. Davood, M.H. Moshafi, A. Sharifian, M. Tabatabaie, H. Tarhimi, G. Sepehri, and A. Shafiee Synthesis and in vitro antibacterial activities of N-substituted piperazinyl quuinolones Pharm. Sci. 3 1997 559 563
7. A. Foroumadi, S. Emmami, P. Haghighat, and M.H. Moshafi Synthesis and in-vitro antibacterial activity of new N-substituted piperazinyl quinolones Pharm. Pharmcol. Commun. 5 1999 591 594
8. A. Foroumadi, M. Safavi, S. Emami, F. Siavoshi, S. Najjari, F. Safari, and A. Shafiee Structure-activity relationship study of a series of N-substituted piperazinyl-fluoroquinolones as anti-Helicobacter pylori agents Med. Chem. 4 2008 498 502
9. T.H. Grasela, S.D. Goodwin, M.K. Walawander, R.L. Cramer, D.W. Fuhs, and V.P. Moriarty Prospective surveillance of intravenous amphotericin B use patterns Pharmacotherapy 10 1990 341 348
10. O. Kondoh, Y. Inagaki, H. Fukuda, E. Mizuguchi, Y. Ohya, M. Arisava, N. Shimma, Y. Aoki, M. Sakaitani, and T. Watanabe Piperazine propanol derivative as a novel antifungal targeting 1, 3-Beta d-glucan synthase Biol. Pharm. Bull. 28 2005 2138 2141
11. Z. Dang, Y. Yang, R. Ji, and S. Zhang Synthesis and antibacterial activity of novel fluoroquinolones containing substituted piperidines Bioorg. Med. Chem. Lett. 17 2007 4523 4526
12. J.M. Domagala, L.D. Hanna, C.L. Heifetz, M.P. Hutt, T.F. Mich, J.P. Sanchez, and M. Solomon New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay J. Med. Chem. 29 1986 394 404
13. K.C. Fang, Y.L. Chen, J.Y. Sheu, T.C. Wang, and C.C. Tzeng Synthesis, antibacterial, and cytotoxic evaluation of certain 7-substituted norfloxacin derivatives J. Med. Chem. 43 2000 3809 3812
14. T. Ito, M. Otsuki, and T. Nishino In vitro antibacterial activity of Q-35, a new fluoroquinolone Antimicrob. Agents Chemother. 36 1992 1708 1714
15. M.E. Jung, E.C. Yang, B.T. Vu, M. Kiankarimi, E. Spyrou, and J. Kaunitz Glycosylation of fluoroquinolones through direct and oxygenated polymethylene linkages as a sugar-mediated active transport system for antimicrobials J. Med. Chem. 42 1999 3899 3909
16. V.T. Andriole Current and future antifungal therapy: new targets for antifungal therapy Int. J. Antimicrob. Chemother. 16 2000 317 321
17. G.P. Bodey Candidosis: Pathogenesis, Diagnosis and Treatment Clinical Oncology vol. 6 1994 Raven New York 371-406
18. J. Onishi, M. Meinz, J. Thompson, J. Curotto, S. Dreikorn, M. Rosenbach, C. Douglas, G. Abruzzo, A. Flattery, L. Kong, A. Cabello, F. Vicente, F. Pelaez, M.T. Diez, I. Martin, G. Bills, R. Glacobbe, A. Dombrowski, R. Schwartz, S. Morris, G. Harris, A. Tsipuras, K. Wilson, and M.B. Kurtz Discovery of novel antifungal (1,3)-β-d-glucan synthase inhibitors Antimicrob. Agents Chemother. 44 2000 368 377
19. J.A. Vazquez, L.M. Dembry, V. Sanchez, M.A. Vazquez, J.D. Sobel, C. Dmuchowski, and M.J. Zervos Nosocomial Candida glabrata colonization: an epidemiologic study J. Clin. Microbiol. 36 1998 421 426
20. M. Sojakova, D. Liptajova, M. Borovsky, and J. Subik Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia Mycopathologia 157 2004 163 169
21. C.A. Lyman, and T.J. Walsh Systemically administered antifungal agents a review of their clinical pharmacology and therapeutic applications Drugs 44 1992 9 35
22. M.J. Nieto, F.L. Alovero, R.H. Manzo, and M.R. Razzieri Benzenesulfonamide analogs of fluoroquinolones - antibacterial activity and QSAR studies Eur. J. Med. Chem. 40 2005 361 363
23. S.N. Pandeya, D. Sriram, G. Nath, and E.D. Clercq Synthesis, antibacterial, antifungal and anti-HIV activities of norfloxacin mannich bases Eur. J. Med. Chem. 35 2000 249 255